Blecha et al. prepared a series of NDGA-analogs to be more potent and selective against MCF-7 breast cancer cells by targeting the IGF-1 receptor (IGF-1R) or 15-LOX (Blecha et al., 2007). The gene discussed is ALOX15; the disease is breast carcinoma.